These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 20572035

  • 1. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
    Karamitopoulou E, Zlobec I, Koumarianou A, Patsouris ES, Peros G, Lugli A.
    Cancer; 2010 Oct 01; 116(19):4474-86. PubMed ID: 20572035
    [Abstract] [Full Text] [Related]

  • 2. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
    Karamitopoulou E, Zlobec I, Panayiotides I, Patsouris ES, Peros G, Rallis G, Lapas C, Karakitsos P, Terracciano LM, Lugli A.
    Hum Pathol; 2011 Dec 01; 42(12):1888-96. PubMed ID: 21664646
    [Abstract] [Full Text] [Related]

  • 3. RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis.
    Zlobec I, Baker K, Terracciano LM, Lugli A.
    Clin Cancer Res; 2008 Jun 15; 14(12):3798-806. PubMed ID: 18559599
    [Abstract] [Full Text] [Related]

  • 4. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y, Kurland BF, Wang J, Bi J, Li W, Rao S, Lan P, Lin T, Lin E.
    Am J Clin Oncol; 2009 Jun 15; 32(3):245-52. PubMed ID: 19451802
    [Abstract] [Full Text] [Related]

  • 5. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS, Tsai YS, Chow NH.
    Urol Oncol; 2004 Jun 15; 22(2):112-8. PubMed ID: 15082007
    [Abstract] [Full Text] [Related]

  • 6. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
    Zlobec I, Minoo P, Baumhoer D, Baker K, Terracciano L, Jass JR, Lugli A.
    Cancer; 2008 Feb 01; 112(3):495-502. PubMed ID: 18076013
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor.
    Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, Watanabe G.
    J Thorac Cardiovasc Surg; 2004 Oct 01; 128(4):517-22. PubMed ID: 15457151
    [Abstract] [Full Text] [Related]

  • 8. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
    Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L, Lugli A.
    Clin Cancer Res; 2008 Jan 01; 14(1):143-8. PubMed ID: 18172264
    [Abstract] [Full Text] [Related]

  • 9. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
    Shariat SF, Tokunaga H, Zhou J, Kim J, Ayala GE, Benedict WF, Lerner SP.
    J Clin Oncol; 2004 Mar 15; 22(6):1014-24. PubMed ID: 14981102
    [Abstract] [Full Text] [Related]

  • 10. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ, Litman H, Viale G, Maffini F, Masullo M, Golouh R, Martinez-Tello FJ, Grigolato P, Shilkin KB, Gusterson BA, Castiglione-Gertsch M, Price K, Lindtner J, Cortés-Funes H, Simoncini E, Byrne MJ, Collins J, Gelber RD, Coates AS, Goldhirsch A, International Breast Cancer Study Group.
    Cancer; 2003 Apr 01; 97(7):1591-600. PubMed ID: 12655514
    [Abstract] [Full Text] [Related]

  • 11. Stage III colorectal cancer: molecular disparity between primary cancers and lymph node metastases.
    Messick CA, Church JM, Liu X, Ting AH, Kalady MF.
    Ann Surg Oncol; 2010 Feb 01; 17(2):425-31. PubMed ID: 19885699
    [Abstract] [Full Text] [Related]

  • 12. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information.
    Ohrling K, Edler D, Hallström M, Ragnhammar P, Blomgren H.
    J Clin Oncol; 2005 Aug 20; 23(24):5628-34. PubMed ID: 16009948
    [Abstract] [Full Text] [Related]

  • 13. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J, Bade S, Hoheisel J, Muley T, Dienemann H, Herpel E.
    Thorac Cardiovasc Surg; 2009 Oct 20; 57(7):403-8. PubMed ID: 19795327
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 15. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE, Karafoka E, Papailiou JG, Stamopoulos P, Zambirinis CP, Bramis K, Panoussopoulos SG, Leandros E, Bramis J.
    Anticancer Res; 2009 Feb 12; 29(2):785-91. PubMed ID: 19331236
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM, Westra JL, de Vries EG, Boersma-van Ek W, Zwart N, Hollema H, Boezen HM, Mulder NH, Plukker JT, de Jong S, Kleibeuker JH, Koornstra JJ.
    J Clin Oncol; 2006 Nov 01; 24(31):4998-5004. PubMed ID: 17075118
    [Abstract] [Full Text] [Related]

  • 17. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
    McKay JA, Douglas JJ, Ross VG, Curran S, Ahmed FY, Loane JF, Murray GI, McLeod HL.
    Clin Cancer Res; 2000 Mar 01; 6(3):1113-8. PubMed ID: 10741741
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.
    Ann Surg; 2007 Dec 01; 246(6):1040-6. PubMed ID: 18043108
    [Abstract] [Full Text] [Related]

  • 19. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P, Greloz V, Oppikofer C, Szalay-Quinodoz I, Herrmann F.
    Cancer; 2004 Jun 01; 100(11):2367-75. PubMed ID: 15160340
    [Abstract] [Full Text] [Related]

  • 20. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS, Kim JH, Yoon SM, Choi EK, Ahn SD, Lee SW, Kim JC, Yu CS, Kim HC, Kim TW, Chang HM.
    Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):796-802. PubMed ID: 19289261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.